This is a video recording of the training session provided by the DUH Infection Prevention and Control Team. The course provided an opportunity to practice donning and doffing PPE in preparation for potential Ebola patients that may present to your clinic. Watch the training session recordings.**
**Please note that in order to view the video, you must be on the Duke Medicine Network as well as signed in using your Duke NetID and password.
As part of our ongoing efforts to actively screen patients for potential risk of infection for Ebola virus, a travel history/risk screening tool has been implemented in the Maestro Care system for areas in which patients are arrived or where first contact potentially occurs across the health system. The new functionality will enable thorough documentation and monitoring of responses to screening questions provided by patients. (More…)
As part of our ongoing Ebola planning and preparedness efforts, Duke infectious disease experts hosted an Ebola information session to share important information with all ambulatory clinic physicians and staff, as well as answered questions from clinics across the health system.
The session includes the latest information about the virus, as well as review DUHS’ infection control system and plans in place to screen and care for patients with a focus on the ambulatory clinic setting.
A subsequent test of a new specimen provided by the patient at Duke University Hospital in Durham has resulted in a confirmed negative laboratory diagnosis for Ebola. This test, conducted 72 hours after an initial test was negative for the virus, confirms the patient is currently Ebola free.
The testing was conducted at the State Laboratory of Public Health, located in the N.C. Department of Health and Human Services (NC DHHS), one of 15 state labs approved by the federal Centers for Disease Control and Prevention to test blood specimens for Ebola. (More…)
The patient who was transported to Duke University Hospital on November 2 with a reported fever and a travel history to West Africa has tested negative for Ebola in a confirmatory lab test. As a result, the patient is considered to be free of the virus. The North Carolina Department of Health and Human Services (NCDHHS) notified Duke of these results this evening which support the findings of the preliminary test conducted on November 3 that was negative for the virus. (More…)
As part of our ongoing Ebola planning and preparedness efforts, Duke infectious disease experts will be hosting an Ebola information session to share important information with all ambulatory clinic physicians and staff, as well as answer questions from clinics across the health system. (More…)
The patient who was transported to Duke University Hospital on November 2, 2014, with a reported fever and a travel history to West Africa has tested negative for Ebola infection in a preliminary lab screening. Duke was notified of the results of this initial test this morning by the North Carolina Department of Health and Human Services who performed the test. A confirming test will be run in 72 hours.
Until Ebola infection is definitively ruled out, the patient will remain under care in a completely contained, isolated and secured unit at Duke University Hospital and all other aspects of Duke’s comprehensive infection control plan remain in place.
The patient’s care team at DUH has undergone extensive training over the past several weeks in caring for such a patient. This patient is being cared for in a separate unit with no other patients, and staff caring for these patients will have no other patient contact during this time. The team has received hours of training in the proper use of personal protective equipment to prevent their exposure to the virus.
As of Sunday evening, November 2, a patient has been admitted to Duke University Hospital for further evaluation and testing for potential Ebola virus infection. We expect to know the results of this test from the N.C. Department of Health and Human Services sometime Monday morning. Meanwhile, the patient is being cared for in the same confined, isolated and secured space in which an actual Ebola patient would be treated. The patient is receiving care from a seasoned team of Duke clinical professionals who have completed extensive training to treat such a patient. We have anticipated this possibility for several weeks now and have a plan in place to manage this situation.
We appreciate that some may be concerned in hearing this news but wanted to review some facts we hope will be helpful.
Duke has planned and prepared.
With world-class infectious disease experts and extensive infection prevention and protection protocols in place, we are confident in our ability to successfully care for this patient while awaiting the results of the Ebola test, and also preventing risk of exposure to the virus if, in fact, it is present.
We have had a comprehensive infection control plan under development since August and have been actively screening all patients for any risk of exposure to Ebola who have presented to Duke University Health System offices and facilities for the past several weeks.
Transmission risk is extremely low and unlikely.
While we don’t yet know this patient’s Ebola status, it’s worth noting that the risk of transmission of the virus to any patients, visitors, employees or healthcare professionals within Duke University Hospital is extremely low and highly unlikely.
Ebola can only be transmitted through contact with the bodily fluids of a patient with the virus. Ebola is not spread through the air like the cold or flu virus.
Importantly, to date, there are no known cases in the U.S. of transmission of Ebola to patients, visitors or family members at the hospitals in which Ebola patients were being treated, or among the family members and acquaintances of the patients themselves.
Safety is our priority.
The team treating the patient has undergone extensive training on the use of personal protective equipment and infection control procedures with Duke’s infectious disease team and the experts in Duke’s state-of-the-art biosafety lab.
Our infectious disease team is in continuous contact with the Centers for Disease Control and Prevention and state and local health departments to monitor any new information related to the virus or care for Ebola patients.
We are committed to caring for all Duke Medicine patients.
While the situation related to caring for this patient, as we await the results of the Ebola test, will be a high priority, our care providers will continue to deliver outstanding care to all Duke Medicine patients.
As one of the leading academic medical centers in the nation, Duke has a history of responding to serious health and medical challenges. Treating this patient is not only consistent with our institutional values and mission, but also aligns to our commitment to our local communities.
As the international community continues to grapple with the numerous challenges associated with the evolving Ebola outbreak in West Africa, the isolated instances in which patients with Ebola have been treated in the U.S. have heightened the need for all hospitals and health systems to be prepared to treat a patient thought to have a significant risk of infection with, or exposure to, Ebola virus. (More…)
Duke University Health System leadership hosted an Ebola information session for physicians, nurse practitioners, physicians assistants and other APPs. DUHS infectious disease experts reviewed the our infection control system and plans in place to effectively screen patients, as well as the steps being taken to mitigate potential risks to our health care teams, patients and visitors should an Ebola patient require our care. Watch a recording of this session on the Duke Medicine Intranet.
**Please note that in order to view this video, you must be on the Duke Medicine Network as well as signed in using your Duke NetID and password.